442 related articles for article (PubMed ID: 7868909)
1. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation.
Casini-Raggi V; Kam L; Chong YJ; Fiocchi C; Pizarro TT; Cominelli F
J Immunol; 1995 Mar; 154(5):2434-40. PubMed ID: 7868909
[TBL] [Abstract][Full Text] [Related]
2. Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease.
Ludwiczek O; Vannier E; Borggraefe I; Kaser A; Siegmund B; Dinarello CA; Tilg H
Clin Exp Immunol; 2004 Nov; 138(2):323-9. PubMed ID: 15498044
[TBL] [Abstract][Full Text] [Related]
3. Functional interactions between mucosal IL-1, IL-ra and TGF-beta 1 in ulcerative colitis.
Ashwood P; Harvey R; Verjee T; Wolstencroft R; Thompson RP; Powell JJ
Inflamm Res; 2004 Feb; 53(2):53-9. PubMed ID: 15021969
[TBL] [Abstract][Full Text] [Related]
4. Evidence of genetic heterogeneity in IBD: 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis.
Bioque G; Bouma G; Crusius JB; Koutroubakis I; Kostense PJ; Meuwissen SG; Peña AS
Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):105-10. PubMed ID: 8723412
[TBL] [Abstract][Full Text] [Related]
5. Relationship of interleukin-1 receptor antagonist to mucosal inflammation in inflammatory bowel disease.
Hyams JS; Fitzgerald JE; Wyzga N; Muller R; Treem WR; Justinich CJ; Kreutzer DL
J Pediatr Gastroenterol Nutr; 1995 Nov; 21(4):419-25. PubMed ID: 8583293
[TBL] [Abstract][Full Text] [Related]
6. Functional correlates of the interleukin-1 receptor antagonist gene polymorphism in the colonic mucosa in ulcerative colitis.
Carter MJ; Jones S; Camp NJ; Cox A; Mee J; Warren B; Duff GW; Lobo AJ; di Giovine FS
Genes Immun; 2004 Jan; 5(1):8-15. PubMed ID: 14735144
[TBL] [Abstract][Full Text] [Related]
7. Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases.
Heresbach D; Alizadeh M; Dabadie A; Le Berre N; Colombel JF; Yaouanq J; Bretagne JF; Semana G
Am J Gastroenterol; 1997 Jul; 92(7):1164-9. PubMed ID: 9219791
[TBL] [Abstract][Full Text] [Related]
8. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
Griga T; Voigt E; Gretzer B; Brasch F; May B
Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
[TBL] [Abstract][Full Text] [Related]
9. Imbalance of the interleukin 1 system in colonic mucosa--association with intestinal inflammation and interleukin 1 receptor antagonist [corrected] genotype 2.
Andus T; Daig R; Vogl D; Aschenbrenner E; Lock G; Hollerbach S; Köllinger M; Schölmerich J; Gross V
Gut; 1997 Nov; 41(5):651-7. PubMed ID: 9414973
[TBL] [Abstract][Full Text] [Related]
10. Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation.
Mazzucchelli L; Hauser C; Zgraggen K; Wagner H; Hess M; Laissue JA; Mueller C
Am J Pathol; 1994 May; 144(5):997-1007. PubMed ID: 8178948
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 receptor antagonist VNTR-polymorphism in inflammatory bowel disease.
Vijgen L; Van Gysel M; Rector A; Thoelen I; Esters N; Ceelen T; Vangoidsenhoven E; Vermeire S; Rutgeerts P; Van Ranst M
Genes Immun; 2002 Nov; 3(7):400-6. PubMed ID: 12424621
[TBL] [Abstract][Full Text] [Related]
12. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation.
Kanazawa S; Tsunoda T; Onuma E; Majima T; Kagiyama M; Kikuchi K
Am J Gastroenterol; 2001 Mar; 96(3):822-8. PubMed ID: 11280558
[TBL] [Abstract][Full Text] [Related]
13. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
[TBL] [Abstract][Full Text] [Related]
14. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.
Banks C; Bateman A; Payne R; Johnson P; Sheron N
J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223
[TBL] [Abstract][Full Text] [Related]
15. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
Sartor RB
Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
[TBL] [Abstract][Full Text] [Related]
16. Colonic mucosal interleukin 1 receptor antagonist in inflammatory bowel disease.
Nishiyama T; Mitsuyama K; Toyonaga A; Sasaki E; Tanikawa K
Digestion; 1994; 55(6):368-73. PubMed ID: 7705549
[TBL] [Abstract][Full Text] [Related]
17. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
Solomon A; Dursun D; Liu Z; Xie Y; Macri A; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2283-92. PubMed ID: 11527941
[TBL] [Abstract][Full Text] [Related]
18. Profile of soluble cytokine receptors in Crohn's disease.
Gustot T; Lemmers A; Louis E; Nicaise C; Quertinmont E; Belaiche J; Roland S; Van Gossum A; Devière J; Franchimont D
Gut; 2005 Apr; 54(4):488-95. PubMed ID: 15753533
[TBL] [Abstract][Full Text] [Related]
19. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India.
Mittal RD; Bid HK; Ghoshal UC
Scand J Gastroenterol; 2005 Jul; 40(7):827-31. PubMed ID: 16109659
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel disease.
Ten Hove T; The Olle F; Berkhout M; Bruggeman JP; Vyth-Dreese FA; Slors JF; Van Deventer SJ; Te Velde AA
J Leukoc Biol; 2004 Jun; 75(6):1010-5. PubMed ID: 15020649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
